11-126406975-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001254757.2(ST3GAL4):c.134C>T(p.Pro45Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000621 in 1,613,912 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001254757.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ST3GAL4 | NM_001254757.2 | c.134C>T | p.Pro45Leu | missense_variant | 4/11 | ENST00000444328.7 | NP_001241686.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ST3GAL4 | ENST00000444328.7 | c.134C>T | p.Pro45Leu | missense_variant | 4/11 | 5 | NM_001254757.2 | ENSP00000394354.2 |
Frequencies
GnomAD3 genomes AF: 0.000487 AC: 74AN: 152066Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000374 AC: 94AN: 251430Hom.: 0 AF XY: 0.000294 AC XY: 40AN XY: 135894
GnomAD4 exome AF: 0.000635 AC: 929AN: 1461846Hom.: 1 Cov.: 32 AF XY: 0.000615 AC XY: 447AN XY: 727230
GnomAD4 genome AF: 0.000487 AC: 74AN: 152066Hom.: 0 Cov.: 32 AF XY: 0.000485 AC XY: 36AN XY: 74290
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 01, 2024 | The c.122C>T (p.P41L) alteration is located in exon 4 (coding exon 3) of the ST3GAL4 gene. This alteration results from a C to T substitution at nucleotide position 122, causing the proline (P) at amino acid position 41 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at